Penn Medicine Provider
Ophthalmology
Benjamin J. Kim, MD
4.7
(793)
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
View 1 additional location

About me

  • Vice-Chair for Clinical Operations
  • Associate Professor of Ophthalmology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Yale University
  • Residency: Mount Auburn Hospital
  • Residency: Massachusetts Eye & Ear Infirmary
  • Fellowship: Johns Hopkins Hospital

What my patients think about me

Average Rating
4.7

793 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
caring,
May 2025
5.0
5.0
he is very efficient
May 2025
5.0
5.0
excellent care.
April 2025
5.0
5.0
dr. kim is wonderful.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kim is a Penn Medicine physician.

Qualifications and experience

My research

Parikh Rupin N, Traband Anastasia, Kolomeyer Anton M, VanderBeek Brian L, Kim Benjamin J, Maguire Albert M, Brucker Alexander J Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy. , American Journal of Ophthalmology, 176: 2017,194-202


Daniel Ebenezer, Grunwald Juan E, Kim Benjamin J, Maguire Maureen G, Jaffe Glenn J, Toth Cynthia A, Ferris Frederick L, Martin Daniel F, Shaffer James, Ying Gui-Shuang Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials. , Ophthalmology Retina, 1(1): 2017,25-33


Kim Benjamin J, Irwin David J, Song Delu, Daniel Ebenezer, Leveque Jennifer D, Raquib Aaishah R, Pan Wei, Ying Gui-Shuang, Aleman Tomas S, Dunaief Joshua L, Grossman Murray Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration. , Neurology, 89(15): 2017,1604-1611


Kolomeyer Anton M, Murphy Kathleen M, Traband Anastasia, Frank Ian, Kim Benjamin J Beta-D-Glucan Testing in Patients with Fungal Endophthalmitis. , Retina (Philadelphia, Pa.), 38(4): 2018,650-659


Cheng Qianqian Ellie, Gao Jeffrey, Kim Benjamin J, Ying Gui-Shuang Design Characteristics of Geographic Atrophy Treatment Trials: Systematic Review of Registered Trials in ClinicalTrials.gov. , Ophthalmology Retina, 2(6): 2018,518-525


Daniel Ebenezer, Pan Wei, Ying Gui-Shuang, Kim Benjamin J, Grunwald Juan E, Ferris Frederick L, Jaffe Glenn J, Toth Cynthia A, Martin Daniel F, Fine Stuart L, Maguire Maureen G Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. , Ophthalmology, 125(7): 2018,1037-1046


Nti Akosua A, Serrano Leona W, Sandhu Harpal S, Uyhazi Katherine E, Edelstein Ilaina D, Zhou Elaine J, Bowman Scott, Song Delu, Gangadhar Tara C, Schuchter Lynn M, Mitnick Sheryl, Huang Alexander, Nichols Charles W, Amaravadi Ravi K, Kim Benjamin J, Aleman Tomas S Frequent Subclinical Macular Changes in Combined BRAF/MEK Inhibition with High-Dose Hydroxychloroquine as Treatment for Metastatic BRAF Mutant Melanoma: Preliminary Results From a Phase I/II Clinical Treatment Trial. , Retina (Philadelphia, Pa.), 39(3): 2019,502-513


Daniel Ebenezer, Ying Gui-Shuang, Kim Benjamin J, Toth Cynthia A, Ferris Frederick, Martin Daniel F, Grunwald Juan E, Jaffe Glenn J, Dunaief Joshua L, Pan Wei, Maguire Maureen G Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. , Ophthalmology, 126(5): 2019,743-751


Kim Benjamin J Utility of Ophthalmic Consultations for Patients With Candidemia. , JAMA Ophthalmology, 137(6): 2019,710-711


Kim Benjamin J, Grossman Murray, Song Delu, Saludades Samantha, Pan Wei, Dominguez-Perez Sophia, Dunaief Joshua L, Aleman Tomas S, Ying Gui-Shuang, Irwin David J Persistent and Progressive Outer Retina Thinning in Frontotemporal Degeneration. , Frontiers in Neuroscience, 13: 2019,298